节律失调的米特拉脱落:我们可以冒险分层并预防心脏突然死亡吗?
James N Cameron1,2, Kadhim I Kadhim3, Suraya Hb Kamsani3
1Department of Cardiology, Austin Health Melbourne, Australia.
Arrhythmia & electrophysiology review
|August 15, 2024
概括
恶性 mitra 透 (MVP) 可以导致心脏突然死亡 (SCD),即使没有严重的 mitra 吐. 风险分层对于管理这些罕见但危险的心律失常至关重要.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 心脏外科手术 心脏外科手术
背景情况:
- 密特拉脱落 (MVP) 越来越多地被认为是心室节律失常和心脏突然死亡 (SCD) 的原因.
- 这种被称为"恶性MVP"的现象,即使没有显著的额叶吐,也可能发生,这表明门力学和左心室功能之间存在复杂的相互作用.
- 有效的风险分层对于管理患有SCD风险的患者至关重要.
研究的目的:
- 为了审查心律失常的米特拉脱落 (MVP).
- 探索MVP相关心律失常的流行病学,临床表现,机制和管理策略.
- 讨论风险分层对于预防心脏突发死亡 (SCD) 的重要性.
主要方法:
- 对有关心律失常性米特拉脱落 (MVP) 的现有文献的综述.
- 对流行病学数据,临床表现以及将MVP与心脏突发死亡 (SCD) 联系起来的机制的分析.
- 评估诊断方式,包括病史,体检,电生理学研究和成像.
主要成果:
- 心室节律失常和心脏突然死亡 (SCD) 是一种罕见的,但已被认可的 mitra valve prolapse (MVP) 的并发症.
- 在MVP患者中,SCD的风险可能与 mitrale regurgitation 的严重程度无关.
- 临床,成像和电生理学数据用于风险分层,但定义一个明确的高风险概况仍然具有挑战性.
结论:
- 节律失常性门缩 (MVP) 是一个重大问题,需要全面评估和风险分层.
- 准确的风险评估对于指导干预至关重要,例如植入式心脏变压器 (ICD) 放置,用于预防突然心脏死亡 (SCD) 的初级预防.
- 需要进一步的研究来优化临床,成像和电生理学数据的整合,以便在MVP患者中精确地分层风险.
相关概念视频
Mitral Valve Prolapse I: Introduction
1.1K
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Mitral Valve Prolapse II: Assessment and Management
1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis II: Clinical features and Diagnostic Tests
557
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805


